XFOR X4 Pharma Year-over-year net earnings per share growth for the last 12 months
High R&D costs and a limited patient pool are constraining the profitability of X4 Pharmaceuticals (XFOR). However, X4 Pharmaceuticals is successfully penetrating the orphan disease market by offering the drug Xolremdi to combat leukocyte deficiency. Revenues are based on insurance fund payments for targeted therapy of WHIM syndrome. Quarterly EPS variation clearly demonstrates profit dynamics, where 77.30 serves as the base value of the parameter.
Comprehensive metric breakdowns and analytics for X4 Pharmaceuticals, Inc (XFOR)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Equity Ratio X4 Pharmaceuticals|XFOR - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Ratio X4 Pharmaceuticals|XFOR - Company Total Debt|Debt to Net Assets Ratio X4 Pharma|XFOR - Company Long-Term Debt|Current Liabilities X4 Pharmaceuticals|Intermediate Coverage Ratio x4pharma.com
- earnings and market multiples details:
XFOR - Net Profit|Projected Future Earnings X4 Pharmaceuticals|XFOR - Price to Earnings Ratio|Future Price to Earnings Multiple X4 Pharma|XFOR - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio X4 Pharma|XFOR - Operating profit EBITDA|Net earnings per share (EPS TTM) X4 Pharmaceuticals|XFOR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months x4pharma.com|XFOR - Earnings growth in current year|Expected net earnings per share growth next year X4 Pharmaceuticals
Basic company analysis:XFOR (X4 Pharmaceuticals, Inc.)
To minimize risks when selecting an issuer, it is critical to assess profit resilience against external shocks. This indicator captures the percentage change in net income per share per quarter, which allows investors to track the commercialization efficiency of WHIM syndrome therapy and innovative drugs from X4 Pharmaceuticals (XFOR) for the treatment of rare immune pathologies via current quarterly EPS dynamics on GURU.Markets.
Direct competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|ADPT: Year-over-year net earnings per share growth for the last 12 months|CLDX (Celldex Corp) - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months Aurinia Pharmaceuticals|Year-over-year net earnings per share growth for the last 12 months biocryst.com|VERA - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months DNTH|PHVS - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth AbCellera Bio (ABCL)|Year-over-year earnings per one share growth for the last 12 months Tourmaline Bio, Inc.|Quarterly EPS earnings growth precigen.com PGEN|Pharming Group - Quarterly EPS earnings growth|NKTR: Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months Upstream Bio Corp UPB|ZBIO (Zenas Corp) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months IMNM|Quarterly EPS earnings growth gossamerbio.com|Quarterly EPS earnings growth KALV|Quarterly EPS earnings growth Septerna, Inc. (SEPN)|Pieris Pharmaceuticals Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Savara Pharma SVRA|RIGL (Rigel Pharmaceuticals) - Earnings per share growth in annualized terms for the last twelve months|anaptysbio.com (ANAB) - Year-over-year net earnings per share growth for the last 12 months|ATXS: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months enGene Holdings Inc|RAPT Therapeutics (RAPT) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth Aerovate|ACRS (Aclaris Therapeutics) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth kyvernatx.com (KYTX)|Tiziana Life Sciences Ltd - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Cabaletta Bio Inc. CABA|Ventyx Bio - Quarterly EPS earnings growth|THTX: Year-over-year earnings per share growth for the last twelve months|Avalo Therapeutics, Inc (AVTX) - Year-over-year earnings per share growth for the last twelve months|ELDN (eledon.com) - Year-over-year earnings per share growth for the last twelve months|AGEN: Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Climb Bio Inc. (CLYM)|Year-over-year earnings per share growth for the last 12 months Zura Bio ZURA|Quarterly EPS earnings growth aTyr Pharmaceuticals (ATYR)|Adagene Inc. (ADAG) - Year-over-year net earnings per share trend for the last twelve months|ImageneBio - Year-over-year earnings per share growth for the last twelve months|STTK (Shattuck Therapeutics) - Earnings per share growth in annualized terms for the last twelve months|EQ: Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months connectbiopharm.com CNTB|IMUX (Immunic) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months Atara Biotherapeutics, Inc. ATRA|Quarterly EPS earnings growth InflaRx GmbH|Adicet Bio (ACET) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth celularity.com (CELU)|Quarterly EPS earnings growth INMB (INmune Bio Corp)|Barinthus Biotherapeutics Corp - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months Kezar Life Sciences (KZR)|SABS: Year-over-year earnings per share growth for the last twelve months|AKTX (Akari Therapeutics Plc) - Year-over-year net earnings per share growth for the last 12 months|Enlivex Therapeutics Ltd. (ENLV) - Quarterly EPS earnings growth|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months GeoVax Corp (GOVX)|Edesa Biotech, Inc. (EDSA) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ibioinc.com (IBIO)|Year-over-year net earnings per share change for the last twelve months CARM|XTL Biopharmaceuticals Ltd - Year-over-year earnings per share growth for the last twelve months|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCWB: Year-over-year earnings per share growth for the last twelve months|APVO (aptevotherapeutics.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months aimimmuno.com|ADTX (Aditxt Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months GRI|Year-over-year earnings per share growth for the last 12 months XORTX XRTX|Quarterly EPS earnings growth Vyome Therapeutics (HIND)|REVB: Earnings per share growth in annualized terms for the last twelve months|INDP - Year-over-year net earnings per share growth for the last 12 months|Scinai Immunotherapeutics Ltd. (SCNI) - Year-over-year earnings per share growth for the last 12 months|CALI (CalciMedica, Inc.) - Year-over-year earnings per share growth for the last 12 months|AFMD (affimed.com) - Year-over-year net earnings per share growth for the last 12 months|Allakos - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Bio - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ITOS|OCEA (Ocean Biomedical Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TCBP (TC BioPharm (Holdings) PLC)|Quarterly EPS earnings growth Third Harmonic Bio Inc THRD
